Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

The gene product Murr1 restricts HIV-1 replication in resting CD4+ lymphocytes.

Ganesh L, Burstein E, Guha-Niyogi A, Louder MK, Mascola JR, Klomp LW, Wijmenga C, Duckett CS, Nabel GJ.

Nature. 2003 Dec 18;426(6968):853-7.

2.
3.

Basal shuttle of NF-kappaB/I kappaB alpha in resting T lymphocytes regulates HIV-1 LTR dependent expression.

Coiras M, López-Huertas MR, Rullas J, Mittelbrunn M, Alcamí J.

Retrovirology. 2007 Aug 8;4:56.

4.

HIV replication in CD4+ T lymphocytes in the presence and absence of follicular dendritic cells: inhibition of replication mediated by α-1-antitrypsin through altered IκBα ubiquitination.

Zhou X, Shapiro L, Fellingham G, Willardson BM, Burton GF.

J Immunol. 2011 Mar 1;186(5):3148-55. doi: 10.4049/jimmunol.1001358. Epub 2011 Jan 24.

5.
6.

COMMD1/Murr1 reinforces HIV-1 latent infection through IκB-α stabilization.

Taura M, Kudo E, Kariya R, Goto H, Matsuda K, Hattori S, Vaeteewoottacharn K, McDonald F, Suico MA, Shuto T, Kai H, Okada S.

J Virol. 2015 Mar;89(5):2643-58. doi: 10.1128/JVI.03105-14. Epub 2014 Dec 17.

7.

Cellular APOBEC3G restricts HIV-1 infection in resting CD4+ T cells.

Chiu YL, Soros VB, Kreisberg JF, Stopak K, Yonemoto W, Greene WC.

Nature. 2005 May 5;435(7038):108-14. Epub 2005 Apr 13. Retraction in: Nature. 2010 Jul 8;466(7303):276.

PMID:
15829920
8.

Inhibition of HIV-1 replication in primary human monocytes by the IkappaB-alphaS32/36A repressor of NF-kappaB.

Palmieri C, Trimboli F, Puca A, Fiume G, Scala G, Quinto I.

Retrovirology. 2004 Dec 21;1:45.

9.

Allo-antigen stimulated CD8+ T-cells suppress NF-κB and Ets-1 DNA binding activity, and inhibit phosphorylated NF-κB p65 nuclear localization in CD4+ T-cells.

Nagashima R, Kawakami F, Takahashi S, Obata F, Kubo M.

Viral Immunol. 2014 Aug;27(6):305-15. doi: 10.1089/vim.2013.0113. Epub 2014 May 20.

11.

Inducible expression of IkappaBalpha repressor mutants interferes with NF-kappaB activity and HIV-1 replication in Jurkat T cells.

Kwon H, Pelletier N, DeLuca C, Genin P, Cisternas S, Lin R, Wainberg MA, Hiscott J.

J Biol Chem. 1998 Mar 27;273(13):7431-40.

12.

Permanent occupancy of the human immunodeficiency virus type 1 enhancer by NF-kappa B is needed for persistent viral replication in monocytes.

Jacqué JM, Fernández B, Arenzana-Seisdedos F, Thomas D, Baleux F, Virelizier JL, Bachelerie F.

J Virol. 1996 May;70(5):2930-8.

13.

Tumor suppressor cylindromatosis (CYLD) controls HIV transcription in an NF-κB-dependent manner.

Manganaro L, Pache L, Herrmann T, Marlett J, Hwang Y, Murry J, Miorin L, Ting AT, König R, García-Sastre A, Bushman FD, Chanda SK, Young JA, Fernandez-Sesma A, Simon V.

J Virol. 2014 Jul;88(13):7528-40. doi: 10.1128/JVI.00239-14. Epub 2014 Apr 23.

15.
17.

NO inhibits cytokine-induced iNOS expression and NF-kappaB activation by interfering with phosphorylation and degradation of IkappaB-alpha.

Katsuyama K, Shichiri M, Marumo F, Hirata Y.

Arterioscler Thromb Vasc Biol. 1998 Nov;18(11):1796-802.

19.
20.

NF-kappaB activation upon interaction of HIV-1 envelope glycoproteins with cell surface CD4 involves IkappaB kinases.

Bossis G, Salinas S, Cartier C, Devaux C, Briant L.

FEBS Lett. 2002 Apr 10;516(1-3):257-64.

Supplemental Content

Support Center